Report: Anthropic buys Coefficient Bio for about $400 million
Anthropic acquired a biotech AI startup founded just eight months earlier.
What happened
According to The Information and Eric Newcomer, Anthropic bought stealth biotech AI startup Coefficient Bio in a stock deal worth about $400 million.
TechCrunch sources confirmed the deal closed but declined to comment on the amount.
What is Coefficient Bio?
- An AI startup focused on drug discovery.
- Founded eight months earlier by Samuel Stanton and Nathan C. Frey.
- Both previously worked in computational drug discovery at Genentech's Prescient Design.
- The team of about 10 people will join Anthropic's health and life sciences team.
Why it matters
Anthropic launched Claude for Life Sciences in October. This deal shows it is serious about using AI for drug discovery.
Founder and editor-in-chief of Kurd Developers. Phone and tech news on YouTube, Instagram and TikTok.
More stories
One text can break your phone: Android's 'SMS of Death' explained
A flaw in Android 12 and later lets a specially crafted SMS drop calls and even make a phone unusable. The fix is in October's security patch.
GTA VI lands November 19: prices, editions and what to know
Rockstar has locked the date: Thursday, November 19 on PS5 and Xbox Series X|S. Standard costs $79.99 and Ultimate $99.99.
Apple's first touchscreen MacBook Pro brings OLED and Dynamic Island
The new PROLED XDR display responds to touch, the notch is gone and Dynamic Island takes its place. Prices start at $2,899.
The $1,999 iPhone Duo Has a Black-Bar Problem, and Fixing It Is Harder Than It Looks
Apple's first foldable is a hardware flex. But unfold it and many of your apps shrink into a phone-shaped window floating in black. Here's why the app world wasn't ready, and why developers can't just hit "stretch".